{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Sauerbrei W"],"funding":["Cancer Research UK"],"pagination":["803-811"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6093349"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["110(8)"],"pubmed_abstract":["The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) were developed to address widespread deficiencies in the reporting of such studies. The REMARK checklist consists of 20 items to report for published tumor marker prognostic studies. A detailed paper was published explaining the rationale behind checklist items, providing positive examples and giving empirical evidence of the quality of reporting. REMARK provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. Despite support for REMARK from major cancer journals, prognostic factor research studies remain poorly reported. To encourage dis"],"journal":["Journal of the National Cancer Institute"],"pubmed_title":["Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration."],"pmcid":["PMC6093349"],"funding_grant_id":["C5529","16895"],"pubmed_authors":["Cavenagh MM","Sauerbrei W","Altman DG","Taube SE","McShane LM"],"additional_accession":[]},"is_claimable":false,"name":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.","description":"The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) were developed to address widespread deficiencies in the reporting of such studies. The REMARK checklist consists of 20 items to report for published tumor marker prognostic studies. A detailed paper was published explaining the rationale behind checklist items, providing positive examples and giving empirical evidence of the quality of reporting. REMARK provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. Despite support for REMARK from major cancer journals, prognostic factor research studies remain poorly reported. To encourage dis","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Aug","modification":"2025-04-19T10:57:17.961Z","creation":"2019-03-27T00:08:05Z"},"accession":"S-EPMC6093349","cross_references":{"pubmed":["29873743"],"doi":["10.1093/jnci/djy088"]}}